SCM
CHRS icon

Sio Capital Management’s Coherus Oncology CHRS Stock Holding History

Sio Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-413,733
Closed -$5.72M – 68
2021
Q2 		$5.72M Sell
413,733
-434,129
-51% -$6.15M 1.42% 21
2021
Q1 		$12.4M Sell
847,862
-16,194
-2% -$275K 2.51% 9
2020
Q4 		$15M Sell
864,056
-180,105
-17% -$3.21M 3.07% 5
2020
Q3 		$19.1M Sell
1,044,161
-91,702
-8% -$1.71M 3.79% 3
2020
Q2 		$20.3M Buy
1,135,863
+58,024
+5% +$982K 5.92% 1
2020
Q1 		$17.5M Buy
1,077,839
+131,078
+14% +$2.42M 5.86% 3
2019
Q4 		$17M Buy
946,761
+341,976
+57% +$6.31M 4.06% 4
2019
Q3 		$12.3M Buy
604,785
+420,419
+228% +$8.4M 3.95% 6
2019
Q2 		$4.07M Buy
+184,366
New +$3.2M 0.98% 36
2017
Q2 		– Sell
-63,800
Closed -$1.35M – 63
2017
Q1 		$1.35M Buy
+63,800
New +$1.57M 0.75% 32
2016
Q4 		– Sell
-73,053
Closed -$1.96M – 46
2016
Q3 		$1.96M Buy
+73,053
New +$1.99M 1.35% 25

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sio Capital Management's CHRS Position: Q3 2021 in Review

Sio Capital Management sold out of Coherus Oncology (CHRS) in Q3 2021, closing a stake of 413,733 shares — an estimated $5.72M sold.

Sio Capital Management first reported a position in CHRS in Q3 2016 and held it in 11 quarters. The position peaked at $20.3M in Q2 2020. 187 funds tracked by Wall St. Rank hold CHRS as of Q3 2021.

  • Sio Capital Management reported no remaining Coherus Oncology position as of Q3 2021 after selling out during the quarter.
  • Sio Capital Management sold 413,733 Coherus Oncology shares in Q3 2021, an estimated $5.72M.
  • Sio Capital Management first reported a position in Coherus Oncology in Q3 2016 and held it in 11 quarters.
  • Sio Capital Management's Coherus Oncology position peaked at $20.3M in Q2 2020.
  • 187 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2021.

Based on Sio Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.